Jiangsu Sihuan Bioengineering (000518.SZ): Qiu Weibi will become the actual controlling shareholder of the company.
Sihuan Biopharmaceutical (000518.SZ) issued an announcement. On January 20, 2025, Bishui Investment received a notification from Jiangyin Court...
Jiangsu Sihuan Bioengineering (000518.SZ) announced that on January 20, 2025, Bi Shui Investment received a "Enforcement Order" (2024) SU0281 Zhi 7624 No. 2 issued by Jiangyin Court. The ownership of 286 million shares of unlimited tradable shares of Jiangsu Sihuan Bioengineering held by Yu Qinfen, Chen Jianguo, and Wang Hongming belongs to Fujian Bi Shui Agricultural Investment Co., Ltd. The ownership of the above-mentioned shares will be transferred to the purchaser Fujian Bi Shui Agricultural Investment Co., Ltd. upon delivery of this order.
The transfer of the company's shares involved in the above judicial order has not been completed yet. According to the "Enforcement Order," once the transfer is completed, it will result in a change of control of the company. Bi Shui Investment will hold 286 million shares of the company, accounting for 27.78% of the total share capital, becoming the new controlling shareholder of the company. Qiu Weibi will become the actual controller of the company.
Related Articles

New Stock Listing News | Jiangxi Biology Submits Application to Hong Kong Stock Exchange for the Second Time, the Company is the Largest Provider of Human TAT in China and Worldwide.

SKYWORTH GROUP (00751) plans to acquire a 40% stake in Fenchai Electronics Company and provide additional capital for it.

ZHEJIANGEXPRESS (00576): Zheshang approved for pilot stock incentive exercise financing business for listed companies.
New Stock Listing News | Jiangxi Biology Submits Application to Hong Kong Stock Exchange for the Second Time, the Company is the Largest Provider of Human TAT in China and Worldwide.

SKYWORTH GROUP (00751) plans to acquire a 40% stake in Fenchai Electronics Company and provide additional capital for it.

ZHEJIANGEXPRESS (00576): Zheshang approved for pilot stock incentive exercise financing business for listed companies.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


